Chemomab Therapeutics | 20-F:年度報告/過渡報告/註冊聲明
03/28 06:14 (美東)
Chemomab Therapeutics | SC 13D/A:超過5%持股股東披露文件(修正)-OrbiMed Israel BioFund GP Limited Partnership(16.0%),OrbiMed Israel GP Ltd.(16.0%)等
03/11 19:23 (美東)
Chemomab Therapeutics | 6-K:外國發行人報告(業績相關)
03/07 07:04 (美東)
Chemomab Therapeutics | 6-K:外國發行人報告
01/03 00:00 (美東)
Chemomab Therapeutics | SC 13D/A:超過5%持股股東披露文件(修正)-OrbiMed Israel BioFund GP Limited Partnership(18.3%),OrbiMed Israel GP Ltd.(18.3%)等
2023/11/15 16:35 (美東)
Chemomab Therapeutics | 6-K:外國發行人報告(業績相關)
2023/11/09 08:00 (美東)
Chemomab Therapeutics | EFFECT:其他
2023/11/06 00:15 (美東)
Chemomab Therapeutics | CORRESP:信函
2023/11/01 16:05 (美東)
Chemomab Therapeutics | F-3/A:交易註冊聲明(修正)
2023/10/30 08:33 (美東)
Chemomab Therapeutics | F-3:交易註冊聲明
2023/10/16 16:25 (美東)
Chemomab Therapeutics | 6-K:外國發行人報告(業績相關)
2023/08/14 08:05 (美東)
Chemomab Therapeutics | 6-K:外國發行人報告
2023/08/08 06:00 (美東)
Chemomab Therapeutics | 4:持股變動聲明-董事 Darvish Nissim
2023/07/05 17:48 (美東)
Chemomab Therapeutics | 6-K:外國發行人報告(業績相關)
2023/07/03 15:49 (美東)
Chemomab Therapeutics | 4:持股變動聲明-董事 Quigley Jill M.
2023/06/20 06:03 (美東)
Chemomab Therapeutics | 4:持股變動聲明-首席財務官 Fatal Sigal
2023/06/16 16:03 (美東)
Chemomab Therapeutics | 8-K:重大事件
2023/06/16 16:01 (美東)
Chemomab Therapeutics | 3:首次持股聲明-首席財務官 Fatal Sigal
2023/06/05 16:54 (美東)
Chemomab Therapeutics | 8-K:重大事件
2023/06/05 07:00 (美東)
Chemomab Therapeutics | RW:註冊提款請求
2023/06/02 16:02 (美東)
暫無數據
暫無數據